Explore the words cloud of the MODulATE project. It provides you a very rough idea of what is the project "MODulATE" about.
The following table provides information about the project.
UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6
There are not information about this coordinator. Please contact Fabio for more information, thanks.
|Coordinator Country||France [FR]|
|Total cost||1˙495˙525 €|
|EC max contribution||1˙495˙525 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2017-03-01 to 2022-02-28|
Take a look of project's partnership.
|1||SORBONNE UNIVERSITE||FR (PARIS)||coordinator||533˙816.00|
|2||UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6||FR (PARIS)||coordinator||0.00|
|3||INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT||FR (PARIS CEDEX 07)||participant||961˙708.00|
Tryptophan (Trp) is an essential amino acid required for protein biosynthesis and is also a biochemical precursor of metabolites which have major effects on mammalian physiology. In the gastrointestinal tract, Trp metabolism can follow three major pathways, all of which are under the control of the gut microbiota: (i) the kynurenin pathway in immune and epithelial cells via indoleamine 2,3-Dioxygenase 1, (ii) the serotonin production pathway in enterochromaffin cells via Trp hydroxylase 1 and (iii) the direct use of Trp by the microorganisms of the gut microbiota into several molecules including ligands of the Aryl Hydrocarbon Receptor. The end products of these pathways play key roles in modulating the immune response, intestinal and metabolic functions and behaviour. Several diseases which involve the gut microbiota in their pathogenesis are also impacted by Trp metabolite. This suggests that the effect of the microbiota in these diseases could be at least partially mediated by impaired Trp metabolism. We recently observed that impaired Trp metabolism by the gut microbiota is involved in inflammatory bowel disease pathogenesis and preliminary data suggest a potential role in other major human diseases. The aims of the current proposal are (i) to identify the components of the gut microbiota, including both bacteria and fungi, involved in the control of the 3 Trp metabolism pathways in the gut, (ii) to decipher the reciprocal equilibrium between the pathways and to evaluate the potential of its modulation as a therapeutic target, and finally (iii) to assess the relevance of these phenomena in human patients. This challenging project will involve multi-disciplinary aspects, from microbiology to metabolism, inflammation and medicine, the use of multiple cutting edge technologies and translational analysis from mice to human. Beside scientific importance, it will have societal impact by identifying new therapeutic strategies in several human diseases with unmet needs.
|year||authors and title||journal||last update|
Michela Miani, Julie Le Naour, Emmanuelle Waeckel-EnÃ©e, Subash chand Verma, MarjolÃ¨ne Straube, Patrick Emond, Bernhard Ryffel, Peter van Endert, Harry Sokol, Julien Diana
Gut Microbiota-Stimulated Innate Lymphoid Cells Support Î²-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes
published pages: 557-572.e6, ISSN: 1550-4131, DOI: 10.1016/j.cmet.2018.06.012
|Cell Metabolism 28/4||2020-04-24|
Ludivine Laurans, Nicolas Venteclef, Yacine Haddad, Mouna Chajadine, Fawaz Alzaid, Sarvenaz Metghalchi, Bruno Sovran, Raphael G. P. Denis, Julien Dairou, Marina Cardellini, Jose-Maria Moreno-Navarrete, Marjolene Straub, Sarah Jegou, Claire McQuitty, Thomas Viel, Bruno Esposito, Bertrand Tavitian, Jacques Callebert, Serge H. Luquet, Massimo Federici, JosÃ© Manuel Fernandez-Real, Remy Burcelin, Jean-Marie Launay, Alain Tedgui, Ziad Mallat, Harry Sokol, Soraya Taleb
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
published pages: 1113-1120, ISSN: 1078-8956, DOI: 10.1038/s41591-018-0060-4
|Nature Medicine 24/8||2020-04-24|
Jane M. Natividad, Allison Agus, Julien Planchais, Bruno Lamas, Anne Charlotte Jarry, Rebeca Martin, Marie-Laure Michel, Caroline Chong-Nguyen, Ronan Roussel, Marjolene Straube, Sarah Jegou, Claire McQuitty, Maude Le Gall, Gregory da Costa, Emmanuelle Lecornet, ChloÃ© Michaudel, Morgane Modoux, Jeremy Glodt, Chantal Bridonneau, Bruno Sovran, Louise Dupraz, Andre Bado, Mathias L. Richard, Philippe Langella, Boris Hansel, Jean-Marie Launay, Ramnik J. Xavier, Henri Duboc, Harry Sokol
Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome
published pages: , ISSN: 1550-4131, DOI: 10.1016/j.cmet.2018.07.001
Bruno Lamas, Jane M. Natividad, Harry Sokol
Aryl hydrocarbon receptor and intestinal immunity
published pages: 1024-1038, ISSN: 1933-0219, DOI: 10.1038/s41385-018-0019-2
|Mucosal Immunology 11/4||2020-04-24|
Allison Agus, Julien Planchais, Harry Sokol
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
published pages: 716-724, ISSN: 1931-3128, DOI: 10.1016/j.chom.2018.05.003
|Cell Host & Microbe 23/6||2020-04-24|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MODULATE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MODULATE" are provided by the European Opendata Portal: CORDIS opendata.